A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.

Clinical trial NCT00410358 · COMPLETED

Trial details

NCT number: NCT00410358
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2006-06-01
Primary completion: 2008-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.